Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Research and practice in thrombosis and haemostasis. 6(7)
- Ereignis
-
Veröffentlichung
- (wo)
-
Dresden
- (wer)
-
Technische Universität Dresden
- (wann)
-
2024
- Urheber
-
Müller, Stephanie
Tittl, Luise
Speed, Victoria
Roberts, Lara
Patel, Jignesh
Patel, Raj
Arya, Roopen
Kucher, Nils
Spirk, David
Sahin, Kurtulus
Beyer-Westendorf, Jan
- URN
-
urn:nbn:de:bsz:14-qucosa2-916381
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Müller, Stephanie
- Tittl, Luise
- Speed, Victoria
- Roberts, Lara
- Patel, Jignesh
- Patel, Raj
- Arya, Roopen
- Kucher, Nils
- Spirk, David
- Sahin, Kurtulus
- Beyer-Westendorf, Jan
- Technische Universität Dresden
Entstanden
- 2024
Ähnliche Objekte (12)
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery
Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry
The management of acute venous thromboembolism in clinical practice : Results from the European PREFER in VTE Registry
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery
Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry
The management of acute venous thromboembolism in clinical practice : Results from the European PREFER in VTE Registry
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery
Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry
The management of acute venous thromboembolism in clinical practice : Results from the European PREFER in VTE Registry